Search

Your search keyword '"Ben-Shoshan, Moshe"' showing total 1,144 results

Search Constraints

Start Over You searched for: Author "Ben-Shoshan, Moshe" Remove constraint Author: "Ben-Shoshan, Moshe"
1,144 results on '"Ben-Shoshan, Moshe"'

Search Results

152. Anaphylaxis Management by Location: data from the Cross-Canada Anaphylaxis Registry (C-CARE)

153. Long-term adherence and risk of allergic reactions in children who attained milk oral immunotherapy maintenance

154. Impact of COVID-19 Restrictions on Anaphylaxis Presentations to the Emergency Department

161. Increased prevalence of autoimmune diseases in children with chronic spontaneous urticaria

162. Dupilumab Significantly Reduces Itch and Hives in Patients With Chronic Spontaneous Urticaria: Results From a Phase 3 Trial (LIBERTY-CSU CUPID Study A)

163. Biomarkers associated with chronic spontaneous urticaria severity in 108 children

164. The Clear Benefit of Epinephrine and Antihistamines, and Questionable Role of Corticosteroids in the Management of Anaphylaxis: 10 Years of Data from the Cross-Canada Anaphylaxis Registry (C-CARE)

165. Bridging knowledge gaps in paediatric chronic urticaria through a video-based educational tool.

171. Successful Milk Oral Immunotherapy Promotes Generation of Casein-Specific CD137+ FOXP3+ Regulatory T Cells Detectable in Peripheral Blood

172. Increased prevalence of Autoimmune Diseases in Children with Chronic Spontaneous Urticaria

173. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

177. Management Strategies Of Idiopathic Anaphylaxis In The Emergency Room: Current Perspectives

182. Prominent Role of Type 2 Immunity in Skin Diseases: Beyond Atopic Dermatitis

183. Supplementary Material 1 - Supplemental material for Prominent Role of Type 2 Immunity in Skin Diseases—Beyond Atopic Dermatitis

184. Additional file 1 of Demographic characteristics associated with food allergy in a Nationwide Canadian Study

185. The international EAACI/GA(2)LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

196. Omalizumab for the Treatment of Bullous Pemphigoid: A Systematic Review of Efficacy and Safety.

198. 11 Is emergency department transfer always required following anaphylaxis and epinephrine use?

199. Definition, aims, and implementation of GA 2 LEN/HAEi Angioedema Centers of Reference and Excellence

200. Definition, aims, and implementation of GA²LEN/HAEi Angioedema Centers of Reference and Excellence

Catalog

Books, media, physical & digital resources